CohBar Inc (fka CWBR)

[codaras]

Agreed!

[hedgeclipper]

IMO a buying opportunity. All the fundamentals still there for CohBar to be the next (and best) NASH play.

[codaras]

Guess it is your typical sell the news.

[codaras]

It will be very interesting to see how todays presentation affects the share price this week.

[TrendTrade2016]

CWBR monster bio taking off!!

[TrendTrade2016]

My next bio monster...CWBR!!!

[hedgeclipper]

Best of breed NASH therapeutic close to human clinicals. NASH is the hottest area in biotech. See Nimbus/Gilead deal for the kind of numbers that are possible for CohBar. Massive upside here folks.

[codaras]

Nice volume and share price increase this week.

[jjr04001]

Kaboomage coming $CWBR

[Renee]

CWBR moved to the Nasdaq from the OTC:

http://otce.finra.org/DLDeletions

[codaras]

CohBar Announces Approval for Listing on the NASDAQ Capital Market

Dec 13, 2017

OTC Disclosure & News Service

-

NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR

[codaras]

CohBar Announces the Appointment of Dr. John Amatruda to its Board

[stocktrademan]

CWBR buy 4.60

















normal chart




log chart

[codaras]

Per their conference call. They company had met all up listing requirements and had started the process.
It generally takes 4-6 weeks to process a listing application. This time frame is variable and may be shortened considerably, if the application raises no issues and the company responds to staff comments.
Week 1. Company submits application for listing and NASDAQ listing Qualifications staff begins its review.
Week 2-3. Staff completes its preliminary review and prepares comment letter.Week 3-4. Company addresses any issues raised by staff.
Week 5-6. Staff completes their review and company is approved for listing
by these guidelines guessing they will announce up list in the next two weeks.

[codaras]

KSS, MD, PhD? @KSSMDPhD · Nov 17

A mitochondrially-derived peptide owned by $CWBR recently shown to abate completely any toxicity to cultured neuronal cells conferred by amyloid proteins. And at low therapeutic concentration. Next step: animal model
guessing this will be announced after Nasdaq uplist in a couple weeks.

[Regis999]

Thank you. I have been interested in the persuasion and Dilbert commic strip Scott Adams is a professional persuader. He is on twitter. I bring this up based upon what you do for a living. I have just finished reading his book Win Bigly.

Thinks I never thought about. So there is also a master persuader out there that has written several books:

https://www.amazon.com/gp/product/150822319X/ref=oh_aui_detailpage_o00_s00?ie=UTF8&psc=1

Imagine being a litigator and being armed with this !!

Regards

[codaras]

Additionally they added it will be done this year.

[codaras]

Per conference call they are currently in the process of uplisting to Nadaq!

[codaras]

Details for the Conference Call and Slide Presentation:
Date: November 13, 2017
Time: 2:00 p.m. (Pacific Time)

Audio, Dial-in U.S. and Canada: 1-888-599-8667
Audio, Dial-in International: 1-719-325-2494
Conference ID# 643238

Slide Presentation – go to www.webex.com, click on the ‘Join’ button and enter Meeting Number 921656999 and Password Q3Call.

[codaras]

If the company can maintain this price through the end of the year they should be eligible to uplist.

[codaras]

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

[LaoTsu]

Very interesting, thanks!

BTW: I wonder if Carbon 60 (C60) is anything worth looking into?

[Regis999]

What's a Safe Obesity Pill Worth? "There’s a gold mine available”- Bloomberg

https://www.bloomberg.com/news/articles/2017-07-04/why-big-pharma-is-struggling-to-profit-from-the-obesity-epidemic

$CWBR

[Regis999]

Yes Hopefully sooner than later uplisting. Extremely important. The website is being revised.

[codaras]

Regis999 in your discussions with the company did you happen to discuss uplisting to Nasdaq? Seems at this price and with the companies potential it would be a no brainer.
Thanks for all your help.

[codaras]

Thank you Sir! Will do

[Regis999]

Here is the near term CWBR catalyst

The company is set to make a presentation at The Liver Meeting 2017 slated for October 20-24, 2017 in Washington D.C.

Go look at page 16 slides in company presentation "CB4209 reduces Liver Fat
(Steatosis)--See slide 3

[Regis999]

CohBar Vision and Background

www.cohbar.com

[Regis999]

CWBR Elevator Summary tinyurl.com/y8pjbbra

[Regis999]

Nice job Codaras !! Ready for an elevator pitch?

[Regis999]

Promo Piece on Book- “Biggest investment opportunity in history.”

https://vimeo.com/234688381

Written by Jim Mellon (shareholder of CohBar) and Al Chalabi, distils extensive recent research into the science of longevity and also highlights the best opportunities for investors to capitalise on advances that have deep implications for all of our futures.

•Billionaire Jim Mellon Master Investor Show 2017—Investing in Longevity—“The New Money Fountain” Wrote new book on Longevity- Juvenescence: Investing in the age of Longevity

Starts at 28:30

45:00 MetFormin 45:15 Talked to Dr. Nir Barzilai 52:51 List of Longevity companies including CohBar 52:41 Shareholder of CohBar

Presentation

[MinnieM]

Thanks and good luck with it.

[codaras]

I think NASH is their first target. IND planned for Q1

[MinnieM]

Mitochondria based therapeutics (MBTs) are the rage these days. Many scientists/companies are doing research in this arena. That's why I wasn't in a hurry to do the research for a couple more weeks. I don't feel in a hurry since I thought the price was too high for where they are now. Apparently, others feel differently. It would have been a great flip from the day I created this board.

Here's a google search on mitochondria based therapeutics. https://www.google.com/search?q=mitochondria+based+therapeutics&rlz=1C1EODB_enUS533US533&oq=mitochondria+based+therapeutics&aqs=chrome..69i57j0.12632j0j8&sourceid=chrome&ie=UTF-8

You'll find a lot of work listed on pubmed also.
https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+based+therapeutics

https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+genome

https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+peptides

I'm hoping to find their preclinical data. From the prospectus dated Oct 5, 2017: https://www.sec.gov/Archives/edgar/data/1522602/000121390017010315/f424b3100517_cohbarinc.htm

All of our pipeline MDPs and MBT candidates are in the pre-clinical stage of development

We are looking at this very early since there hasn't been a ph1 safety trial yet on any of their drug candidates. Was a trial start date mentioned in the call? Has an IND been submitted to the FDA?

It will be interesting to follow their progress. All of these companies targeting anti-aging and healthspan are of great interest to me. It seems that diabetes and alzheimer's are common targets for them.

[codaras]

I actually just learned of the company yesterday. I have only done surface DD outside of what I learned on the call. I did buy a starter position yesterday. I do have a link for the call but it is on the subscription side of Stock Gumshoe and they consider it proprietary info so I don't feel comfortable sharing it. Sorry.
What I liked: The science is potentially life altering. They are the only company currently pursuing this angle through the mitochondria. They have a tremendous IP portfolio. Their officers appear to be 1st class. They have gotten to the point of be ready to start human trials with only raising 18 million dollars. That is pretty much unheard of. They did issue an s-1 in September for a little over 6 million shares at about 2.70 a share. So the price may pull back some from yesterday. I am not shilling for the other sight but Dr. KSS is unparalleled in his willingness to share his knowledge and answer questions pertaining to biotech. I have an oversized (for me) investment in ARTH which is how I found out about SG and Dr. Kss. He thinks this may be the most exciting company He has found in years.

[MinnieM]

I do a lot of reading on both Alzheimers Disease drugs in development and age related research leading to various supplements sold since there are a lot of crossover areas. During the course of that reading I ran into this company.

My search history shows me doing a google search on the company 9.19.17 and if memory serves me correctly, I was researching some claims made by a scientist in the same field of research as Sinclair when I ran across it. I still haven't had time to take a close look at it. That's why I didn't invest.

All I've done is create a doc with the basic info that is a starting point for my research and put a couple of the links into the creation of the board for the next person that runs into this company here on iHub. Plus, I have it on my favourite list to make it easy to see when there is activity. My creation of this board was just random, like many of the others I've created when I notice there isn't an existing board for a company I'm looking at.

Do you have a link to the conference call? I'd like to hear it.

It's likely that you know more about the company than I do. ;)

Are you invested here? And, if so, what is it that you like about them?








In Reply to 'codaras'
I am curious. Where did you first hear about this company? Guessing you will have more SG people checking in here after yesterday's conference call.

[codaras]

I am curious. Where did you first hear about this company? Guessing you will have more SG people checking in here after yesterday's conference call.

[MinnieM]

Should have bought shares the day I created this board on 9.20.17. I created it to make it easier to watch since I use iHub regularly. All it's done is go up since.